Table 1.
Comparison of demographic and clinical parameters between T2DM cases and controls of the study
| Variables | controls (n=58) | T2DM cases (n=118) | p-value |
| Age (years) | 42.81 ± 9.82 | 57.48 ± 9.09 | <0.0001* |
| Body Mass Index (Kg/m2) | 24.31 ± 3.29 | 24.66 ± 4.09 | >0.567 |
|
Serum fasting glucose (mg/dl) |
90.97 ± 6.55 | 246.53 ± 77.94 | <0.0001* |
| HbA1c (%) | 5.24 ± 4.66 | 11.42 ± 2.76 | <0.0001* |
|
Serum T. Cholesterol (mg/dl) |
156.31 ± 30.09 | 177.91 ± 48.02 | <0.002* |
| Serum Triglyceride (mg/dl) | 145.31 ± 35.38 | 179.16 ± 66.44 | <0.0001* |
|
Serum LDL- cholesterol (mg/dl) |
106.60 ± 25.23 | 121.23 ± 33.33 | <0.004* |
|
Serum HDL- cholesterol (mg/dl) |
33.85 ± 4.49 | 34.62 ± 8.09 | >0.496 |
| Serum Creatinine (mg/dl) | 0.73 ± 0.16 | 1.47 ± 2.11 | <0.010* |
variables were considered statistically significant when p value < 0.05.